Literature DB >> 31262201

Oligomeric α-synuclein is increased in basal tears of Parkinson's patients.

Sarah F Hamm-Alvarez1,2, Curtis T Okamoto2, Srikanth R Janga1, Danielle Feigenbaum3, Maria C Edman1, Daniel Freire3, Mihir Shah1, Raveena Ghanshani1,3, Wendy J Mack4, Mark F Lew3.   

Abstract

Aim: Secretion of proteins into basal tears of Parkinson's disease (PD) patients may be altered by changes in nerve function. Materials & methods: Oligomeric α-SynOligo and total α-SynTotal, CCL-2, DJ-1, LF and MMP-9 were measured in basal tears from 93 PD patients and 82 age- and sex-equivalent healthy controls.
Results: α-SynTotal was decreased (p = 0.0043), whereas α-SynOligo (p < 0.0001) and the ratio of α-SynOligo/α-SynTotal (p < 0.0001) were increased in basal tears from PD patients compared with healthy controls. Area under receiver-operating curves of α-SynOligo and α-SynOligo/α-SynTotal contents were 0.70 (95% confidence limits: 0.621-0.774) and 0.72 (95% confidence limits: 0.642-0.792).
Conclusion: PD patient basal tears may contain biomarkers that can be assayed noninvasively and inexpensively.

Entities:  

Keywords:  Parkinson’s disease; biofluid; biomarker; oligomeric α-synuclein; tears; α-synuclein

Mesh:

Substances:

Year:  2019        PMID: 31262201     DOI: 10.2217/bmm-2019-0167

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  6 in total

1.  Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.

Authors:  Chao-Wen Lin; Tzu-Ting Lai; Szu-Ju Chen; Chin-Hsien Lin
Journal:  Geroscience       Date:  2022-04-28       Impact factor: 7.581

2.  A Pilot Study of Changes in the Level of Catecholamines and the Activity of α-2-Macroglobulin in the Tear Fluid of Patients with Parkinson's Disease and Parkinsonian Mice.

Authors:  Vsevolod Bogdanov; Alexander Kim; Marina Nodel; Tatiana Pavlenko; Ekaterina Pavlova; Victor Blokhin; Natalia Chesnokova; Michael Ugrumov
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

3.  Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration.

Authors:  Marlies Gijs; Inez H G B Ramakers; Pieter Jelle Visser; Frans R J Verhey; Marjo P H van de Waarenburg; Casper G Schalkwijk; Rudy M M A Nuijts; Carroll A B Webers
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

4.  Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.

Authors:  Shruti Singh Kakan; Maria C Edman; Alexander Yao; Curtis T Okamoto; Annie Nguyen; Brooke E Hjelm; Sarah F Hamm-Alvarez
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

Review 5.  Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.

Authors:  Pedro Magalhães; Hilal A Lashuel
Journal:  NPJ Parkinsons Dis       Date:  2022-07-22

Review 6.  Tear Biomarkers in Alzheimer's and Parkinson's Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review).

Authors:  Angelika Król-Grzymała; Edyta Sienkiewicz-Szłapka; Ewa Fiedorowicz; Dominika Rozmus; Anna Cieślińska; Andrzej Grzybowski
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.